191 related articles for article (PubMed ID: 35959376)
21. [The relevance of tumor necrosis factor-alpha gene-863C/A polymorphism with thyroid-associated ophthalmopathy].
Yan SL; Wang YX
Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):786-90. PubMed ID: 16191343
[TBL] [Abstract][Full Text] [Related]
22. Diversity of bacteria at healthy human conjunctiva.
Dong Q; Brulc JM; Iovieno A; Bates B; Garoutte A; Miller D; Revanna KV; Gao X; Antonopoulos DA; Slepak VZ; Shestopalov VI
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5408-13. PubMed ID: 21571682
[TBL] [Abstract][Full Text] [Related]
23. Optimisation of methods for bacterial skin microbiome investigation: primer selection and comparison of the 454 versus MiSeq platform.
Castelino M; Eyre S; Moat J; Fox G; Martin P; Ho P; Upton M; Barton A
BMC Microbiol; 2017 Jan; 17(1):23. PubMed ID: 28109256
[TBL] [Abstract][Full Text] [Related]
24. Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.
Wang Y; Smith TJ
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1735-48. PubMed ID: 24651704
[TBL] [Abstract][Full Text] [Related]
25. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
[TBL] [Abstract][Full Text] [Related]
26. IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy.
Fang S; Huang Y; Zhong S; Zhang Y; Liu X; Wang Y; Gu P; Zhou H; Fan X
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6123-6133. PubMed ID: 27832278
[TBL] [Abstract][Full Text] [Related]
27. RETINAL MICROVASCULATURE ALTERATION IN ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY.
Ye L; Zhou SS; Yang WL; Bao J; Jiang N; Min YL; Yuan Q; Tan G; Shen M; Shao Y
Endocr Pract; 2018 Jul; 24(7):658-667. PubMed ID: 30048168
[TBL] [Abstract][Full Text] [Related]
28. Serelaxin Alleviates Fibrosis in Thyroid-Associated Ophthalmopathy via the Notch Pathway.
Sun A; Ye H; Xu Z; Chen J; Xiao W; Zhang T; Sha X; Bi S; Zhou T; Yang H
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176063
[TBL] [Abstract][Full Text] [Related]
29. Decreased Expression of TIM-3 on Th17 Cells Associated with Ophthalmopathy in Patients with Graves' Disease.
Zhao J; Lin B; Deng H; Zhi X; Li Y; Liu Y; Bible PW; Li Q; Xu B; Wei L; Yang H; Huang D
Curr Mol Med; 2018; 18(2):83-90. PubMed ID: 29974826
[TBL] [Abstract][Full Text] [Related]
30. Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.
Sieminska L; Niedziolka D; Pillich A; Kos-Kudla B; Marek B; Nowak M; Borgiel-Marek H
J Endocrinol Invest; 2008 Sep; 31(9):745-9. PubMed ID: 18997483
[TBL] [Abstract][Full Text] [Related]
31. Decreased microRNA-146a in CD4+T cells promote ocular inflammation in thyroid-associated ophthalmopathy by targeting NUMB.
Hu ZJ; He JF; Li KJ; Chen J; Xie XR
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1803-1809. PubMed ID: 28485799
[TBL] [Abstract][Full Text] [Related]
32. [Peripapillary and macular vessel density in eyes with different phases of thyroid-associated ophthalmopathy].
Wang YH; Ma J; Li H; Xu HY; Gan LY; Zhang X; Wang XQ; Zhong Y
Zhonghua Yan Ke Za Zhi; 2020 Nov; 56(11):824-831. PubMed ID: 33152840
[No Abstract] [Full Text] [Related]
33. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies.
Eckstein AK; Finkenrath A; Heiligenhaus A; Renzing-Köhler K; Esser J; Krüger C; Quadbeck B; Steuhl KP; Gieseler RK
Acta Ophthalmol Scand; 2004 Jun; 82(3 Pt 1):291-7. PubMed ID: 15115450
[TBL] [Abstract][Full Text] [Related]
34. Establishment of magnetic resonance imaging 3D reconstruction technology of orbital soft tissue and its preliminary application in patients with thyroid-associated ophthalmopathy.
Shen J; Jiang W; Luo Y; Cai Q; Li Z; Chen Z; Hu S; Tang L
Clin Endocrinol (Oxf); 2018 May; 88(5):637-644. PubMed ID: 29412482
[TBL] [Abstract][Full Text] [Related]
35. Advances in artificial intelligence in thyroid-associated ophthalmopathy.
Yi C; Niu G; Zhang Y; Rao J; Liu G; Yang W; Fei X
Front Endocrinol (Lausanne); 2024; 15():1356055. PubMed ID: 38715793
[TBL] [Abstract][Full Text] [Related]
36. [The influence factors of quality-of-life in patients with thyroid-associated ophthalmopathy].
Shen L; Zhu H; Li XX; Liu DD; Chen XY; Liu H
Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):575-582. PubMed ID: 28851197
[No Abstract] [Full Text] [Related]
37. Evaluation of retinal and choroidal variations in thyroid-associated ophthalmopathy using optical coherence tomography angiography.
Yu L; Jiao Q; Cheng Y; Zhu Y; Lin Z; Shen X
BMC Ophthalmol; 2020 Oct; 20(1):421. PubMed ID: 33081749
[TBL] [Abstract][Full Text] [Related]
38. Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy.
Li Z; Wang M; Tan J; Zhu L; Zeng P; Chen X; Xie L; Duan R; Chen B; Tao T; Wang R; Wang X; Su W
Cell Rep Med; 2022 Aug; 3(8):100699. PubMed ID: 35896115
[TBL] [Abstract][Full Text] [Related]
39. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].
Wu T; Tang DR; Wang F; Xia S; Sun FY
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264
[No Abstract] [Full Text] [Related]
40. Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.
Huang D; Xu N; Song Y; Wang P; Yang H
Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):619-25. PubMed ID: 22124787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
